跳至主要内容
临床试验/NCT07599683
NCT07599683招募中不适用

Effect of Low Dose Galactose on Glycaemia and Glucose Kinetics

University of Bath1 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2026年1月1日最近更新:
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
25
试验地点
1

研究概览

简要总结

This project will establish the degree to which adding low-dose galactose to a meal can control blood sugar levels. People will consume standardised glucose drinks (75g glucose, as an oral glucose tolerance test). People will consume these with and without the addition of galactose, and with the addition of another sugar (fructose) for an extra comparison. The investigators will use state-of-the-art labelling methods (dual stable isotope technology) to follow what happens to the glucose that is ingested and understand what happens to sugar being released by the liver and sugar being taken up by other tissues like the muscles. These methods can tell the investigators how the addition of galactose can control blood sugar levels. For example, the galactose could slow down the appearance of glucose from the gut and/or liver released into the blood, or it could increase the disappearance of glucose from the blood into muscles. The investigators will measure the appearance of the label on exhaled breath, which will establish whether ingested sugar is stored, or burned as fuel. The investigators will also explore other potential ways in which galactose might control blood sugar levels by measuring key hormones and metabolites that contribute to blood sugar control (for example, insulin, fatty acids, and incretin hormones which potentiate insulin secretion). This additional evidence of how galactose can control blood sugar levels will provide the understanding required to best make use of this approach across a variety of settings.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age: 18 years and above;
  • Normoglycaemic (fasting glucose <6.1 mmol/L)
  • Body mass index: 18.5-30 kg/m2

排除标准

  • weight instability (>5% change within last 3 months);
  • pregnant or lactating;
  • following a very low-carbohydrate (ketogenic) diet;
  • diagnosis of diabetes or prediabetes, or any other metabolic disease;
  • dietary intolerances or allergies, or to any other study procedures;
  • disorders in the ability to metabolise galactose or fructose (e.g., galactosemias);
  • diagnosis of any gastrointestinal disorders;
  • any other condition/medications that could introduce bias;
  • unable to understand and follow study procedures

研究组 & 干预措施

CONTROL

Sham Comparator

75 g oral glucose tolerance test

干预措施: Glucose Powder (Dietary Supplement)

GALACTOSE

Experimental

75 g oral glucose tolerance test plus 7.5 g galactose

干预措施: Glucose Powder (Dietary Supplement)

FRUCTOSE

Active Comparator

75 g oral glucose tolerance test plus 7.5 g fructose

干预措施: Glucose Powder (Dietary Supplement)

GALACTOSE

Experimental

75 g oral glucose tolerance test plus 7.5 g galactose

干预措施: galactose (Dietary Supplement)

FRUCTOSE

Active Comparator

75 g oral glucose tolerance test plus 7.5 g fructose

干预措施: fructose (Dietary Supplement)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Javier Gonzalez

Professor of Nutrition and Metabolism

University of Bath

研究点 (1)

Loading locations...

相似试验

Effect of Low Dose Galactose on Glycaemia and... | 临床试验